[Blood coagulation disorder in neonatal hemolytic disease, released by an inhibitor in the second clotting phase].
D000991:Antithrombins; D001778:Blood Coagulation Disorders / Q000209:etiology*; D001779:Blood Coagulation Factors; D002199:Capillary Permeability; D004899:Erythroblastosis, Fetal / Q000097:blood*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007231:Infant, Newborn; D010923:Placenta Previa; D011247:Pregnancy
D000991:Antithrombins; D001779:Blood Coagulation Factors
Blutgerinnungsstörung bei Morbus haemolyticus neonatorum, ausgelöst durch einen Hemmkörper der 2. Gerinnungsphase.